| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Cellular and Structural Biology (R.K.T., Y.L., S.C.A., C.S.S., B.C., A.K.R.) The University of Texas Health Science Center at San Antonio and Audie L. Murphy Memorial Veterans Affairs Hospital (B.C.) San Antonio, Texas 78284
An expression construct containing the cDNA
encoding a modified aequorea green fluorescent protein (GFP) ligated to
the 5'-end of the rat androgen receptor (AR) cDNA (GFP-AR) was used to
study the intracellular dynamics of the receptor movement in living
cells. In three different cell lines, i.e. PC3, HeLa, and
COS1, unliganded GFP-AR was seen mostly in the cytoplasm and rapidly
(within 1560 min) moved to the nuclear compartment after androgen
treatment. Upon androgen withdrawal, the labeled AR migrated back to
the cytoplasmic compartment and maintained its ability to reenter the
nucleus on subsequent exposure to androgen. Under the condition of
inhibited protein synthesis by cycloheximide (50 µg/ml), at least
four rounds of receptor recycling after androgen treatment and
withdrawal were recorded. Two nonandrogenic hormones, 17ß-estradiol
and progesterone at higher concentrations
(10-7/10-6
M), were able to both transactivate the
AR-responsive promoter and translocate the GFP- AR into the nucleus.
Similarly, antiandrogenic ligands, cyproterone acetate and casodex,
were also capable of translocating the cytoplasmic AR into the nucleus
albeit at a slower rate than the androgen 5
-dihydrotestosterone
(DHT). All AR ligands with transactivation potential, including the
mixed agonist/antagonist cyproterone acetate, caused translocation of
the GFP-AR into a subnuclear compartment indicated by its punctate
intranuclear distribution. However, translocation caused by casodex, a
pure antagonist, resulted in a homogeneous nuclear distribution.
Subsequent exposure of the casodex-treated cell to DHT rapidly (1530
min) altered the homogeneous to punctate distribution of the already
translocated nuclear AR. When transported into the nucleus either by
casodex or by DHT, GFP-AR was resistant to 2 M
NaCl extraction, indicating that the homogeneously distributed AR is
also associated with the nuclear matrix. Taken together, these results
demonstrate that AR requires ligand activation for its nuclear
translocation where occupancy by only agonists and partial agonists can
direct it to a potentially functional subnuclear location and that one
receptor molecule can undertake multiple rounds of hormonal signaling;
this indicates that ligand dissociation/inactivation rather than
receptor degradation may play a critical role in terminating hormone
action.
This article has been cited by other articles:
![]() |
M. Lombardi, G. Castoria, A. Migliaccio, M. V. Barone, R. Di Stasio, A. Ciociola, D. Bottero, H. Yamaguchi, E. Appella, and F. Auricchio Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells J. Cell Biol., July 28, 2008; 182(2): 327 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Shank, J. B. Kelley, D. Gioeli, C.-S. Yang, A. Spencer, L. A. Allison, and B. M. Paschal Activation of the DNA-dependent Protein Kinase Stimulates Nuclear Export of the Androgen Receptor in Vitro J. Biol. Chem., April 18, 2008; 283(16): 10568 - 10580. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Cutress, H. C. Whitaker, I. G. Mills, M. Stewart, and D. E. Neal Structural basis for the nuclear import of the human androgen receptor J. Cell Sci., April 1, 2008; 121(7): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-x. Zhao, M. Tian, B.-x. Zhao, G.-d. Li, B. Liu, Y.-y. Zhan, H.-z. Chen, and Q. Wu Orphan Receptor TR3 Attenuates the p300-Induced Acetylation of Retinoid X Receptor-{alpha} Mol. Endocrinol., December 1, 2007; 21(12): 2877 - 2889. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Agler, M. Prack, Yingjie Zhu, J. Kolb, K. Nowak, R. Ryseck, Ding Shen, M. E. Cvijic, J. Somerville, S. Nadler, et al. A High-Content Glucocorticoid Receptor Translocation Assay for Compound Mechanism-of-Action Evaluation J Biomol Screen, December 1, 2007; 12(8): 1029 - 1041. [Abstract] [PDF] |
||||
![]() |
B. Cinar, N. K. Mukhopadhyay, G. Meng, and M. R. Freeman Phosphoinositide 3-Kinase-independent Non-genomic Signals Transit from the Androgen Receptor to Akt1 in Membrane Raft Microdomains J. Biol. Chem., October 5, 2007; 282(40): 29584 - 29593. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Kesler, D. Gioeli, M. R. Conaway, M. J. Weber, and B. M. Paschal Subcellular Localization Modulates Activation Function 1 Domain Phosphorylation in the Androgen Receptor Mol. Endocrinol., September 1, 2007; 21(9): 2071 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Birrell, L. M. Butler, J. M. Harris, G. Buchanan, and W. D. Tilley Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer FASEB J, August 1, 2007; 21(10): 2285 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Nickols and P. B. Dervan Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide PNAS, June 19, 2007; 104(25): 10418 - 10423. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakauchi, K.-i. Matsuda, I. Ochiai, A. Kawauchi, Y. Mizutani, T. Miki, and M. Kawata A Differential Ligand-mediated Response of Green Fluorescent Protein-tagged Androgen Receptor in Living Prostate Cancer and Non-prostate Cancer Cell Lines J. Histochem. Cytochem., June 1, 2007; 55(6): 535 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sun, V. Montana, K. Chellappa, Y. Brelivet, D. Moras, Y. Maeda, V. Parpura, B. M. Paschal, and F. M. Sladek Phosphorylation of a Conserved Serine in the Deoxyribonucleic Acid Binding Domain of Nuclear Receptors Alters Intracellular Localization Mol. Endocrinol., June 1, 2007; 21(6): 1297 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, M. E Andersen, S. Heber, and Q. Zhang Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression J. Mol. Endocrinol., May 1, 2007; 38(5): 569 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haelens, T. Tanner, S. Denayer, L. Callewaert, and F. Claessens The Hinge Region Regulates DNA Binding, Nuclear Translocation, and Transactivation of the Androgen Receptor Cancer Res., May 1, 2007; 67(9): 4514 - 4523. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. I. Klokk, P. Kurys, C. Elbi, A. K. Nagaich, A. Hendarwanto, T. Slagsvold, C.-Y. Chang, G. L. Hager, and F. Saatcioglu Ligand-Specific Dynamics of the Androgen Receptor at Its Response Element in Living Cells Mol. Cell. Biol., March 1, 2007; 27(5): 1823 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shao, K. Ljungstrom, B. Weijdegard, E. Egecioglu, J. Fernandez-Rodriguez, F.-P. Zhang, A. Thurin-Kjellberg, C. Bergh, and H. Billig Estrogen-induced upregulation of AR expression and enhancement of AR nuclear translocation in mouse fallopian tubes in vivo Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E604 - E614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Arnett-Mansfield, J. D. Graham, A. R. Hanson, P. A. Mote, A. Gompel, L. L. Scurr, N. Gava, A. de Fazio, and C. L. Clarke Focal Subnuclear Distribution of Progesterone Receptor Is Ligand Dependent and Associated with Transcriptional Activity Mol. Endocrinol., January 1, 2007; 21(1): 14 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kraus, D. Gioeli, T. Vomastek, V. Gordon, and M. J. Weber Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor. Cancer Res., November 15, 2006; 66(22): 11047 - 11054. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chuan, S.-T. Pang, A. Cedazo-Minguez, G. Norstedt, A. Pousette, and A. Flores-Morales Androgen Induction of Prostate Cancer Cell Invasion Is Mediated by Ezrin J. Biol. Chem., October 6, 2006; 281(40): 29938 - 29948. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Butler, M. M. Centenera, P. J. Neufing, G. Buchanan, C. S. Y. Choong, C. Ricciardelli, K. Saint, M. Lee, A. Ochnik, M. Yang, et al. Suppression of Androgen Receptor Signaling in Prostate Cancer Cells by an Inhibitory Receptor Variant Mol. Endocrinol., May 1, 2006; 20(5): 1009 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gioeli, B. E. Black, V. Gordon, A. Spencer, C. T. Kesler, S. T. Eblen, B. M. Paschal, and M. J. Weber Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization Mol. Endocrinol., March 1, 2006; 20(3): 503 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Kim, Y. I. Park, and M.-S. Dong Effects of 2,4-D and DCP on the DHT-Induced Androgenic Action in Human Prostate Cancer Cells Toxicol. Sci., November 1, 2005; 88(1): 52 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ilagan, L. J. Zhang, J. Pottratz, K. Le, S. Salas, M. Iyer, L. Wu, S. S. Gambhir, and M. Carey Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model Mol. Cancer Ther., November 1, 2005; 4(11): 1662 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Farla, R. Hersmus, J. Trapman, and A. B. Houtsmuller Antiandrogens prevent stable DNA-binding of the androgen receptor J. Cell Sci., September 15, 2005; 118(18): 4187 - 4198. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Mills, L. Gaughan, C. Robson, T. Ross, S. McCracken, J. Kelly, and D. E. Neal Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors J. Cell Biol., July 18, 2005; 170(2): 191 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. M. Schaaf, L. J. Lewis-Tuffin, and J. A. Cidlowski Ligand-Selective Targeting of the Glucocorticoid Receptor to Nuclear Subdomains Is Associated with Decreased Receptor Mobility Mol. Endocrinol., June 1, 2005; 19(6): 1501 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Feige, L. Gelman, C. Tudor, Y. Engelborghs, W. Wahli, and B. Desvergne Fluorescence Imaging Reveals the Nuclear Behavior of Peroxisome Proliferator-activated Receptor/Retinoid X Receptor Heterodimers in the Absence and Presence of Ligand J. Biol. Chem., May 6, 2005; 280(18): 17880 - 17890. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Walther, E. Atlas, A. Carrigan, Y. Rouleau, A. Edgecombe, L. Visentin, C. Lamprecht, G. C. Addicks, R. J. G. Hache, and Y. A. Lefebvre A Serine/Threonine-rich Motif Is One of Three Nuclear Localization Signals That Determine Unidirectional Transport of the Mineralocorticoid Receptor to the Nucleus J. Biol. Chem., April 29, 2005; 280(17): 17549 - 17561. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gaughan, I. R. Logan, D. E. Neal, and C. N. Robson Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation Nucleic Acids Res., January 7, 2005; 33(1): 13 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-F. Lin, B.-X. Zhao, H.-Z. Chen, X.-F. Ye, C.-Y. Yang, H.-Y. Zhou, M.-Q. Zhang, S.-C. Lin, and Q. Wu RXR{alpha} acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-dependent manner in gastric cancer cells J. Cell Sci., November 1, 2004; 117(23): 5609 - 5621. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Whitaker, S. Hanrahan, N. Totty, S. C. Gamble, J. Waxman, A. C. B. Cato, H. C. Hurst, and C. L. Bevan Androgen Receptor Is Targeted to Distinct Subcellular Compartments in Response to Different Therapeutic Antiandrogens Clin. Cancer Res., November 1, 2004; 10(21): 7392 - 7401. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Lin, Y.-C. Hu, D. K. Lee, and C. Chang Regulation of Androgen Receptor Signaling by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Tumor Suppressor through Distinct Mechanisms in Prostate Cancer Cells Mol. Endocrinol., October 1, 2004; 18(10): 2409 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dong, D. L. Stenoien, J. Qiu, M. A. Mancini, and D. J. Tweardy Reduced Intranuclear Mobility of APL Fusion Proteins Accompanies Their Mislocalization and Results in Sequestration and Decreased Mobility of Retinoid X Receptor {alpha} Mol. Cell. Biol., May 15, 2004; 24(10): 4465 - 4475. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Black, M. J. Vitto, D. Gioeli, A. Spencer, N. Afshar, M. R. Conaway, M. J. Weber, and B. M. Paschal Transient, Ligand-Dependent Arrest of the Androgen Receptor in Subnuclear Foci Alters Phosphorylation and Coactivator Interactions Mol. Endocrinol., April 1, 2004; 18(4): 834 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Arnett-Mansfield, A. deFazio, P. A. Mote, and C. L. Clarke Subnuclear Distribution of Progesterone Receptors A and B in Normal and Malignant Endometrium J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1429 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ochiai, K.-i. Matsuda, M. Nishi, H. Ozawa, and M. Kawata Imaging Analysis of Subcellular Correlation of Androgen Receptor and Estrogen Receptor {alpha} in Single Living Cells Using Green Fluorescent Protein Color Variants Mol. Endocrinol., January 1, 2004; 18(1): 26 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lee, R. W. Thompson, J. M. McClung, and J. A. Carson Regulation of androgen receptor expression at the onset of functional overload in rat plantaris muscle Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1076 - R1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Saporita, Q. Zhang, N. Navai, Z. Dincer, J. Hahn, X. Cai, and Z. Wang Identification and Characterization of a Ligand-regulated Nuclear Export Signal in Androgen Receptor J. Biol. Chem., October 24, 2003; 278(43): 41998 - 42005. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Lee and C. Chang Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4043 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, M. Johnson, K. H. Le, M. Sato, R. Ilagan, M. Iyer, S. S. Gambhir, L. Wu, and M. Carey Interrogating Androgen Receptor Function in Recurrent Prostate Cancer Cancer Res., August 1, 2003; 63(15): 4552 - 4560. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. DonCarlos, D. Garcia-Ovejero, S. Sarkey, L. M. Garcia-Segura, and I. Azcoitia Androgen Receptor Immunoreactivity in Forebrain Axons and Dendrites in the Rat Endocrinology, August 1, 2003; 144(8): 3632 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Le, C. M. Schaldach, G. L. Firestone, and L. F. Bjeldanes Plant-derived 3,3'-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells J. Biol. Chem., May 30, 2003; 278(23): 21136 - 21145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. M. Schaaf and J. A. Cidlowski Molecular Determinants of Glucocorticoid Receptor Mobility in Living Cells: the Importance of Ligand Affinity Mol. Cell. Biol., March 15, 2003; 23(6): 1922 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jia, J. Kim, H. Shen, P. E. Clark, W. D. Tilley, and G. A. Coetzee Androgen Receptor Activity at the Prostate Specific Antigen Locus: Steroidal and Non-Steroidal Mechanisms Mol. Cancer Res., March 1, 2003; 1(5): 385 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liao, L.-Y. Chen, A. Zhang, A. Godavarthy, F. Xia, J. C. Ghosh, H. Li, and J. D. Chen Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT J. Biol. Chem., February 7, 2003; 278(7): 5052 - 5061. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Okada, Y. Fujii, J. P. Moore Jr., and S. J. Winters Androgen Receptors in Gonadotrophs in Pituitary Cultures from Adult Male Monkeys and Rats Endocrinology, January 1, 2003; 144(1): 267 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Rivera, C. S. Song, V. E. Centonze, J. D. Lechleiter, B. Chatterjee, and A. K. Roy Role of the Promyelocytic Leukemia Body in the Dynamic Interaction between the Androgen Receptor and Steroid Receptor Coactivator-1 in Living Cells Mol. Endocrinol., January 1, 2003; 17(1): 128 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Matsuda, I. Ochiai, M. Nishi, and M. Kawata Colocalization and Ligand-Dependent Discrete Distribution of the Estrogen Receptor (ER){alpha} and ER{beta} Mol. Endocrinol., October 1, 2002; 16(10): 2215 - 2230. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gioeli, S. B. Ficarro, J. J. Kwiek, D. Aaronson, M. Hancock, A. D. Catling, F. M. White, R. E. Christian, R. E. Settlage, J. Shabanowitz, et al. Androgen Receptor Phosphorylation. REGULATION AND IDENTIFICATION OF THE PHOSPHORYLATION SITES J. Biol. Chem., August 2, 2002; 277(32): 29304 - 29314. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gaughan, I. R. Logan, S. Cook, D. E. Neal, and C. N. Robson Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the Receptor J. Biol. Chem., July 12, 2002; 277(29): 25904 - 25913. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. DeFranco Navigating Steroid Hormone Receptors through the Nuclear Compartment Mol. Endocrinol., July 1, 2002; 16(7): 1449 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Pawlowski, J. R. Ertel, M. P. Allen, M. Xu, C. Butler, E. M. Wilson, and M. E. Wierman Liganded Androgen Receptor Interaction with beta -Catenin. NUCLEAR CO-LOCALIZATION AND MODULATION OF TRANSCRIPTIONAL ACTIVITY IN NEURONAL CELLS J. Biol. Chem., May 31, 2002; 277(23): 20702 - 20710. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Mulholland, H. Cheng, K. Reid, P. S. Rennie, and C. C. Nelson The Androgen Receptor Can Promote beta -Catenin Nuclear Translocation Independently of Adenomatous Polyposis Coli J. Biol. Chem., May 10, 2002; 277(20): 17933 - 17943. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saitoh, R. Takayanagi, K. Goto, A. Fukamizu, A. Tomura, T. Yanase, and H. Nawata The Presence of Both the Amino- and Carboxyl-Terminal Domains in the AR Is Essential for the Completion of a Transcriptionally Active Form with Coactivators and Intranuclear Compartmentalization Common to the Steroid Hormone Receptors: A Three-Dimensional Imaging Study Mol. Endocrinol., April 1, 2002; 16(4): 694 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Akiyama, C. T. Baumann, S. Sakai, G. L. Hager, and F. J. Gonzalez Selective Intranuclear Redistribution of PPAR Isoforms by RXR{alpha} Mol. Endocrinol., April 1, 2002; 16(4): 707 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Holter, N. Kotaja, S. Makela, L. Strauss, S. Kietz, O. A. Janne, J.-A. Gustafsson, J. J. Palvimo, and E. Treuter Inhibition of Androgen Receptor (AR) Function by the Reproductive Orphan Nuclear Receptor DAX-1 Mol. Endocrinol., March 1, 2002; 16(3): 515 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishi, H. Ogawa, T. Ito, K.-I. Matsuda, and M. Kawata Dynamic Changes in Subcellular Localization of Mineralocorticoid Receptor in Living Cells: In Comparison with Glucocorticoid Receptor using Dual-Color Labeling with Green Fluorescent Protein Spectral Variants Mol. Endocrinol., July 1, 2001; 15(7): 1077 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Bunn, J. A. Neidig, K. E. Freidinger, T. A. Stankiewicz, B. S. Weaver, J. McGrew, and L. A. Allison Nucleocytoplasmic Shuttling of the Thyroid Hormone Receptor {{alpha}} Mol. Endocrinol., April 1, 2001; 15(4): 512 - 533. [Abstract] [Full Text] |
||||
![]() |
Y. Wan, K. K. Coxe, V. G. Thackray, P. R. Housley, and S. K. Nordeen Separable Features of the Ligand-Binding Domain Determine the Differential Subcellular Localization and Ligand-Binding Specificity of Glucocorticoid Receptor and Progesterone Receptor Mol. Endocrinol., January 1, 2001; 15(1): 17 - 31. [Abstract] [Full Text] |
||||
![]() |
A. Tomura, K. Goto, H. Morinaga, M. Nomura, T. Okabe, T. Yanase, R. Takayanagi, and H. Nawata The Subnuclear Three-dimensional Image Analysis of Androgen Receptor Fused to Green Fluorescence Protein J. Biol. Chem., July 20, 2001; 276(30): 28395 - 28401. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |